Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
作者信息
Baddley John W
机构信息
University of Maryland School of Medicine and Baltimore VA Medical Center, Baltimore, Maryland, USA.
出版信息
Clin Infect Dis. 2022 Jan 7;74(1):92-94. doi: 10.1093/cid/ciab259.
Abstract
摘要
相似文献
1
Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?2019冠状病毒病相关肺曲霉病：我们有能力改善治疗结果吗？
Clin Infect Dis. 2022 Jan 7;74(1):92-94. doi: 10.1093/cid/ciab259.
2
Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis.多国观察性队列研究：COVID-19 相关肺曲霉病。
Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174. Epub 2021 Sep 14.
3
Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.COVID-19 相关急性呼吸窘迫综合征患者侵袭性肺曲霉病。
Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan;69(1):48-53. doi: 10.1016/j.redare.2021.02.007. Epub 2022 Jan 7.
4
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.比较 COVID-19 相关肺曲霉病（CAPA）的临床特征和结局：系统评价和荟萃分析。
Infection. 2022 Feb;50(1):43-56. doi: 10.1007/s15010-021-01701-x. Epub 2021 Sep 27.
5
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病诊断与临床管理特别工作组报告
Intensive Care Med. 2021 Aug;47(8):819-834. doi: 10.1007/s00134-021-06449-4. Epub 2021 Jun 23.
6
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.COVID-19 气管插管患者侵袭性肺曲霉病的流行病学：一项前瞻性研究。
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065.
7
COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.深圳市一家三级保健中心的 COVID-19 相关肺曲霉病。
J Infect Public Health. 2022 Feb;15(2):222-227. doi: 10.1016/j.jiph.2021.12.015. Epub 2022 Jan 6.
8
Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.新型冠状病毒病相关的机械通气患者肺曲霉病。
Clin Infect Dis. 2022 Jan 7;74(1):83-91. doi: 10.1093/cid/ciab223.
9
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).COVID-19 相关危重症患者的肺部曲霉病。
Med Mycol. 2021 Jan 4;59(1):110-114. doi: 10.1093/mmy/myaa078.
10
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.危重症 2019 冠状病毒病（COVID-19）相关肺曲霉病的危险因素：一项全国性、多中心、回顾性队列研究。
J Korean Med Sci. 2022 May 9;37(18):e134. doi: 10.3346/jkms.2022.37.e134.
引用本文的文献
1
A 67-Year-Old Man with a History of COVID-19 Infection, Cough, and Hemoptysis.一名67岁男性，有新冠病毒感染、咳嗽和咯血病史。
Tanaffos. 2024 Jan;23(1):97-99.
2
Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病中真菌生物标志物的诊断性能及纵向分析
Heliyon. 2023 Oct 26;9(11):e21721. doi: 10.1016/j.heliyon.2023.e21721. eCollection 2023 Nov.
3
The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan.约旦首例 COVID-19 后哮喘患者肺孢子菌的检测。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):784-790. doi: 10.17305/bjbms.2022.7335.
4
When Viruses Meet Fungi: Tackling the Enemies in Hematology.当病毒遇上真菌：应对血液学中的敌人
J Fungi (Basel). 2022 Feb 13;8(2):184. doi: 10.3390/jof8020184.
5
Detection of in Patients with Severe COVID-19: Diagnostic and Therapeutic Challenges.重症新型冠状病毒肺炎患者中[具体检测对象]的检测：诊断与治疗挑战。 （注：原文中“Detection of in”部分缺失具体检测内容）
J Fungi (Basel). 2021 Jul 22;7(8):585. doi: 10.3390/jof7080585.
Zotero 插件